Discovered by British scientists a new drug for the treatment of migraine has highly effective addition to the lack of symptoms side effects compared to treatments other, it hinders activity of chemicals that cause Anaqbada in blood vessels. According to L'Express on Thursday that the
study published in the journal Lancet confirmed that the new drug "Tillekajipant" has the effectiveness of the drug "Treptanz", which is the most commonly used for migraine headaches or migraine. However, the new drug leaves fewer side effects.
The description of each of Lars Advinson University Hospital of Lund in Sweden, and Mattias Lindy from Norwegian University of Science and Technology, the new drug as promising, but called for further investigation for it.
It is worth mentioning that around six million Britons suffer from migraine headaches, and eat Treptanz treatment to alleviate it.
0 Comments:
Post a Comment